FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Moliterno

Research Profile

Procedures

Chemicals & Drugs

Disorders

Concepts & Ideas

Devices

Stents

Co-author Network

Publications

TOP 3
Ahmed Abdel-Latif; David J Moliterno
Remote ischemic preconditioning in elective percutaneous coronary intervention does not protect myocardium nor mobilize endothelial progenitor cells.
Matthew G Whitbeck; Milagros M Zegarra; Khaled M Ziada; Paul Anaya; Rong Bai; Alison L Bailey; David C Booth; Charles L Campbell; Richard Charnigo; Luigi Di Biase; John Gurley; Guillaume Jondeau; Paul Khairy; Tracy Macaulay; David J Moliterno; Gustavo Morales; Hafez Nasr; Andrea Natale; Denis Roy; Jignesh Shah; Susan Smyth; Vincent L Sorrell; Claude S Elayi
Increased mortality among patients taking digoxin--analysis from the AFFIRM study.
Nishant Kalra; David J Moliterno
Zotarolimus-eluting stents among patients with renal impairment undergoing percutaneous coronary intervention.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Moliterno (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Ahmed Abdel-Latif; David J Moliterno
Remote ischemic preconditioning in elective percutaneous coronary intervention does not protect myocardium nor mobilize endothelial progenitor cells.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2013;81(6):937-8.
2013: Matthew G Whitbeck; Milagros M Zegarra; Khaled M Ziada; Paul Anaya; Rong Bai; Alison L Bailey; David C Booth; Charles L Campbell; Richard Charnigo; Luigi Di Biase; John Gurley; Guillaume Jondeau; Paul Khairy; Tracy Macaulay; David J Moliterno; Gustavo Morales; Hafez Nasr; Andrea Natale; Denis Roy; Jignesh Shah; Susan Smyth; Vincent L Sorrell; Claude S Elayi
Increased mortality among patients taking digoxin--analysis from the AFFIRM study.
European heart journal 2013;34(20):1481-8.
2012: Nishant Kalra; David J Moliterno
Zotarolimus-eluting stents among patients with renal impairment undergoing percutaneous coronary intervention.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2012;80(6):893-4.
2012: Paul Anaya; David J Moliterno
CT angiography for emergency decision making in acute coronary syndromes: applying future vision now.
Current cardiology reports 2012;14(5):537-9.
2012: D Capodanno; S Goto; David J Moliterno; M L O'Donoghue; C Tamburino; Deepak L Bhatt; D J Angiolillo
Safety and efficacy of protease-activated receptor-1 antagonists in patients with coronary artery disease: a meta-analysis of randomized clinical trials.
Journal of thrombosis and haemostasis : JTH 2012;10(10):2006-15.
2012: Wael El Mallah; David J Moliterno
Early and late outcome associated with bleeding events in the setting of dual antiplatelet therapy following stent placement.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2012;80(3):406-7.
2012: Matthew E Wiisanen; David J Moliterno
Platelet protease-activated receptor antagonism in cardiovascular medicine.
Coronary artery disease 2012;23(6):375-9.
2012: Lawrence Rajan; David J Moliterno
New anticoagulants in ischemic heart disease.
Current cardiology reports 2012;14(4):450-6.
2012: Sean van Diepen; Paul W Armstrong; Justin A Ezekowitz; Christian W Hamm; Judith S Hochman; Stefan James; Renato D Lopes; Kenneth W Mahaffey; David J Moliterno; Franz-Josef Neumann; L Kristin Newby; Matthew T Roe; Amanda L Stebbins; Pierre Theroux; Christopher B Granger
Baseline NT-proBNP and biomarkers of inflammation and necrosis in patients with ST-segment elevation myocardial infarction: insights from the APEX-AMI trial.
Journal of thrombosis and thrombolysis 2012;34(1):106-13.
2012: Eric L Wallace; Ahmed Abdel-Latif; Bruce Brodie; Richard Charnigo; Rahul Matnani; David J Moliterno; Khaled M Ziada
Meta-analysis of long-term outcomes for drug-eluting stents versus bare-metal stents in primary percutaneous coronary interventions for ST-segment elevation myocardial infarction.
The American journal of cardiology 2012;109(7):932-40.
2012: Joseph D Foley; David J Moliterno
Contemporary occurrence of stent thrombosis in clinical practice: better never than late.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2012;79(4):557-8.
2012: Ahmed Abdel-Latif; David J Moliterno
Creating biodegradable-polymer drug-eluting stents: shortening the duration of polymer and dual antiplatelet therapy while lengthening the follow-up.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2012;79(2):217-8.
2011: David P Faxon; David R Holmes; David J Moliterno; Richard C Becker; Peter B Berger; Deepak L Bhatt; John W Eikelboom; Dominick J Angiolillo
Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: a North American perspective: executive summary.
Circulation. Cardiovascular interventions 2011;4(5):522-34.
2011: Eric L Wallace; David J Moliterno
The use of drug-eluting stents versus bypass surgery for left main coronary artery disease.
Current cardiology reports 2011;13(5):361-3.
2011: Lawrence Rajan; David J Moliterno
Beyond aspirin and clopidogrel: is there a need for additional antiplatelet therapy in ACS?
Current cardiology reports 2011;13(4):303-11.
2011: Claude S Elayi; John C Gurley; Bahram Kakavand; Yaariv Khaykin; Tracy E Macaulay; David J Moliterno; Gustavo Morales; Andrea Natale; Abhijit Patwardhan; Jignesh Shah; Sergio Thal; Atul Verma; Matthew G Whitbeck; Rong Bai; Conor Barrett; Richard Charnigo; Chi Keong Ching; Luigi Di Biase
Is there an association between external cardioversions and long-term mortality and morbidity? Insights from the Atrial Fibrillation Follow-up Investigation of Rhythm Management study.
Circulation. Arrhythmia and electrophysiology 2011;4(4):465-9.
2011: Pierluigi Tricoci; Frans Van de Werf; Harvey D White; Paul W Armstrong; Leonardo Bolognese; Eugene Braunwald; Robert M Califf; Eric Durand; Robert P Giugliano; Vic Hasselblad; David F Kong; David J Moliterno; L Kristin Newby; Dorairaj Prabhakaran; Saman Rasoul; Gregg W Stone; Pierre Théroux; Robert A Harrington
Upstream use of small-molecule glycoprotein iib/iiia inhibitors in patients with non-ST-segment elevation acute coronary syndromes: a systematic overview of randomized clinical trials.
Circulation. Cardiovascular quality and outcomes 2011;4(4):448-58.
2011: David J Moliterno
A randomized two-by-two comparison of high-dose bolus tirofiban versus abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary revascularization and stent placement: the tirofiban evaluation of novel dosing versus abciximab with clopidogrel and inhibition of thrombin (TENACITY) study trial.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2011;77(7):1001-9.
2011: Claude S Elayi; Christopher L Allen; Steve Leung; Stephanie Lusher; Gustavo X Morales; Matthew Wiisanen; Shamik Aikat; Bahram Kakavand; Jignesh S Shah; David J Moliterno; John C Gurley
Inside-out access: a new method of lead placement for patients with central venous occlusions.
Heart rhythm : the official journal of the Heart Rhythm Society 2011;8(6):851-7.
2011: Paul Anaya; David J Moliterno
Patient, heal thyself: the ongoing evolution of patient self-directed care and hand-held technology.
Annals of internal medicine 2011;154(7):500-1.
2011: David J Moliterno
Unfractionated versus low-molecular-weight heparin for primary angioplasty-More data suggesting to go low.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2011;77(2):191-2.
2011: David J Moliterno
ACP Journal Club. Increased doses of clopidogrel or aspirin did not prevent cardiovascular events.
Annals of internal medicine 2011;154(2):JC1-7.
2011: Khaled M Ziada; Richard Charnigo; David J Moliterno
Long-term follow-up of drug-eluting stents placed in the setting of ST-segment elevation myocardial infarction.
JACC. Cardiovascular interventions 2011;4(1):39-41.
2010: Ahmed Abdel-Latif; David J Moliterno
Editorial: protein C and S deficiency as a risk factor for stent thrombosis--when a rare disorder can predispose to rare events.
Journal of interventional cardiology 2010;23(6):565-8.
2010: David R Holmes; Dean J Kereiakes; Scot Garg; Patrick Washington Serruys; Gregory J Dehmer; Stephen G Ellis; David O Williams; Takeshi Kimura; David J Moliterno
Stent thrombosis.
Journal of the American College of Cardiology 2010;56(17):1357-65.
2010: Andrea H Tackett; Alison L Bailey; Joanne Micale Foody; Julie M Miller; Carolyn Apperson-Hansen; E Magnus Ohman; Judith S Hochman; Sharon L Karnash; Robert M Califf; Eric J Topol; David J Moliterno
Hormone replacement therapy among postmenopausal women presenting with acute myocardial infarction: insights from the GUSTO-III trial.
American heart journal 2010;160(4):678-84.
2010: David J Moliterno
Rotational atherectomy for resistant chronic total occlusions: another spin for tough old problems.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2010;76(3):372-3.
2010: Matthew E Wiisanen; David J Moliterno
The use of single versus dual antiplatelet therapy beyond 1 year following drug-eluting stent implantation.
Current cardiology reports 2010;12(5):357-60.
2010: Robert T Means; David J Moliterno; G Roxanne Allison; Jay Perman; Richard P Lofgren; Michael Karpf; Frederick C Debeer
The evolution of a Department of Internal Medicine under an integrated clinical enterprise model: the University of Kentucky experience.
Academic medicine : journal of the Association of American Medical Colleges 2010;85(3):531-7.
2010: Marco Valgimigli; Giuseppe Biondi-Zoccai; Matteo Tebaldi; Arnoud W J van't Hof; Gianluca Campo; Christian Hamm; Jurriën ten Berg; Leonardo Bolognese; Francesco Saia; gian battista danzi; Carlo Briguori; Ertan Okmen; Spencer B King; David J Moliterno; Eric J Topol
Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trials.
European heart journal 2010;31(1):35-49.
2009: Debabrata Mukherjee; David J Moliterno
Second-generation drug-eluting stents and the continuous need for rapidly available real-world data.
JACC. Cardiovascular interventions 2009;2(12):1236-9.
2009: Sorin J Brener; Cynthia M Westerhout; Yuling Fu; Thomas G Todaro; David J Moliterno; Galen S Wagner; Christopher B Granger; Paul W Armstrong
Contribution of angiographic and electrocardiographic parameters of reperfusion to prediction of mortality and morbidity after acute ST-elevation myocardial infarction: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial.
American heart journal 2009;158(5):755-60.
2009: Renato D Lopes; Erik Ohman; Christopher B Granger; Emily Honeycutt; Kevin J Anstrom; Peter B Berger; Eric M Crespo; Gustavo B F Oliveira; Stephan Moll; David J Moliterno; Charles S Abrams; Richard C Becker
Six-month follow-up of patients with in-hospital thrombocytopenia during heparin-based anticoagulation (from the Complications After Thrombocytopenia Caused by Heparin [CATCH] registry).
The American journal of cardiology 2009;104(9):1285-91.
2009: Ahmed Abdel-Latif; David J Moliterno
Prasugrel versus clopidogrel in primary PCI: considerations of the TRITON-TIMI 38 substudy.
Current cardiology reports 2009;11(5):323-4.
2009: David J Moliterno
Left main and multivessel coronary artery stenting for patients deemed inoperable-A real need for a tandem approach.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2009;74(2):311-2.
2009: E Marc Jolicoeur; Erik Ohman; Emily Honeycutt; Richard C Becker; Eric M Crespo; Gustavo B F Oliveira; David J Moliterno; Kevin J Anstrom; Christopher B Granger
Contribution of bleeding and thromboembolic events to in-hospital mortality among patients with thrombocytopenia treated with heparin.
The American journal of cardiology 2009;104(2):292-7.
2009: David R Holmes; Dean J Kereiakes; Neal S Kleiman; David J Moliterno; Giuseppe Patti; Cindy L Grines
Combining antiplatelet and anticoagulant therapies.
Journal of the American College of Cardiology 2009;54(2):95-109.
2009: Lawrence Rajan; David J Moliterno
Options and outcomes with different antiplatelet strategies during primary percutaneous coronary intervention.
European heart journal 2009;30(14):1687-9.
2009: Ahmed Abdel-Latif; David J Moliterno
Antiplatelet polypharmacy in primary percutaneous coronary intervention: trying to understand when more is better.
Circulation 2009;119(25):3168-70.
2009: Sharat Koul; David J Moliterno
Bare-metal versus drug-eluting stent placement among patients presenting with anemia.
JACC. Cardiovascular interventions 2009;2(4):337-8.
2009: Tracy Y Wang; Min Zhang; Yuling Fu; Paul W Armstrong; L Kristin Newby; C Michael Gibson; David J Moliterno; Frans Van de Werf; Harvey D White; Robert A Harrington; Matthew T Roe
Incidence, distribution, and prognostic impact of occluded culprit arteries among patients with non-ST-elevation acute coronary syndromes undergoing diagnostic angiography.
American heart journal 2009;157(4):716-23.
2009: Eric M Crespo; Gustavo B F Oliveira; Emily F Honeycutt; Richard C Becker; Peter B Berger; David J Moliterno; Kevin J Anstrom; Charles S Abrams; Neal S Kleiman; Stephan Moll; Lawrence Rice; Jo E Rodgers; Steven R Steinhubl; Victor F Tapson; Christopher B Granger; Erik Ohman
Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (CATCH) registry.
American heart journal 2009;157(4):651-7.
2009: Susan Smyth; Donna S Woulfe; Jeffrey I Weitz; Christian Gachet; Pamela B Conley; Shaun G Goodman; Matthew T Roe; Athan Kuliopulos; David J Moliterno; Patricia A French; Steven R Steinhubl; Richard C Becker
G-protein-coupled receptors as signaling targets for antiplatelet therapy.
Arteriosclerosis, thrombosis, and vascular biology 2009;29(4):449-57.
2009: Richard C Becker; David J Moliterno; Lisa K Jennings; Karen S Pieper; Jinglan Pei; Alan Niederman; Khaled M Ziada; Gail Berman; John Strony; Diane Joseph; Kenneth W Mahaffey; Frans Van de Werf; Enrico Veltri; Robert A Harrington
Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study.
Lancet 2009;373(9667):919-28.
2009: Debabrata Mukherjee; David J Moliterno
Effectiveness of PCI for non-acute coronary artery disease.
Lancet 2009;373(9667):870-2.
2009: Faisal Latif; Neal S Kleiman; David J Cohen; Michael J Pencina; Chen-Hsing Yen; Donald E Cutlip; David J Moliterno; Deborah Nassif; John J Lopez; Jorge F Saucedo
In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry.
JACC. Cardiovascular interventions 2009;2(1):37-45.
2008: David J Moliterno
Advances in antiplatelet therapy for ACS and PCI.
Journal of interventional cardiology 2008;21 Suppl 1():S18-24.
2008: Deepak L Bhatt; James M Scheiman; Neena S Abraham; Elliott M Antman; Francis K L Chan; Curt D Furberg; David A Johnson; Kenneth W Mahaffey; Eamonn M Quigley; Robert A Harrington; Eric R Bates; Charles R Bridges; Mark J Eisenberg; Victor A Ferrari; Mark A Hlatky; Sanjay Kaul; Jonathan R Lindner; David J Moliterno; Debabrata Mukherjee; Richard S Schofield; Robert S Rosenson; James H Stein; Howard H Weitz; Deborah J Wesley
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use.
The American journal of gastroenterology 2008;103(11):2890-907.
2008: Deepak L Bhatt; James M Scheiman; Neena S Abraham; Elliott M Antman; Francis K L Chan; Curt D Furberg; David A Johnson; Kenneth W Mahaffey; Eamonn M Quigley; Robert A Harrington; Eric R Bates; Charles R Bridges; Mark J Eisenberg; Victor A Ferrari; Mark A Hlatky; Sanjay Kaul; Jonathan R Lindner; David J Moliterno; Debabrata Mukherjee; Richard S Schofield; Robert S Rosenson; James H Stein; Howard H Weitz; Deborah J Wesley
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.
Journal of the American College of Cardiology 2008;52(18):1502-17.
2008: Hussam Hamdalla; David J Moliterno
Late drug-eluting stent thrombosis in unprotected left main coronary artery lesions--sometimes possible, but rarely definite or probable.
European heart journal 2008;29(17):2064-6.
2008: David J Moliterno
Racial differences in outcome following percutaneous coronary intervention.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2008;72(1):45-6.
2008: Ali K Salah; Agha Ahmed; Kunal N Bodiwala; Elizabeth John Manaloor; John W Thornton; David J Moliterno
Cardiac amyloidosis.
The Canadian journal of cardiology 2008;24(5):e35.
2008: David J Moliterno
Late percutaneous recanalization of totally occluded infarct-related arteries--more than about time.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2008;71(6):782-3.
2008: Sorin J Brener; David J Moliterno; Philip E Aylward; Arnoud W J van't Hof; Witold Ruźyllo; William W O'Neill; Christian W Hamm; Cynthia M Westerhout; Christopher B Granger; Paul W Armstrong
Reperfusion after primary angioplasty for ST-elevation myocardial infarction: predictors of success and relationship to clinical outcomes in the APEX-AMI angiographic study.
European heart journal 2008;29(9):1127-35.
2008: Ali Salah; David J Moliterno; Roger Humphries; Mushabbar A Syed
Role of cardiac computed tomography and magnetic resonance imaging in the evaluation of acute chest pain in the emergency department.
The international journal of cardiovascular imaging 2008;24(3):331-42.
2008: Gian M Novaro; Craig R Asher; Deepak L Bhatt; David J Moliterno; Robert A Harrington; A Michael Lincoff; L Kristin Newby; James E Tcheng; Amy P Hsu; Sergio L Pinski
Meta-analysis comparing reported frequency of atrial fibrillation after acute coronary syndromes in Asians versus whites.
The American journal of cardiology 2008;101(4):506-9.
2008: David J Moliterno
Late target lesion revascularization following drug-eluting stents - looking back and forward to success.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2008;71(3):304-5.
2008: David J Moliterno; Khaled M Ziada
The safety and efficacy of glycoprotein IIb/IIIa inhibitors for primary angioplasty: more options to choose and more time to decide.
Journal of the American College of Cardiology 2008;51(5):536-7.
2008: Debabrata Mukherjee; David J Moliterno
Effectiveness of drug-eluting stents in real-world patients.
JAMA : the journal of the American Medical Association 2008;299(4):454-5.
2008: Gustavo B F Oliveira; Eric M Crespo; Richard C Becker; Emily Honeycutt; Charles S Abrams; Kevin J Anstrom; Peter B Berger; Linda Davidson-Ray; Eric L Eisenstein; Neal S Kleiman; David J Moliterno; Stephan Moll; Lawrence Rice; Jo E Rodgers; Steven R Steinhubl; Victor F Tapson; Erik Ohman; Christopher B Granger
Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapy.
Archives of internal medicine 2008;168(1):94-102.
2007: Harshawardhan M Mardikar; M S Hiremath; David J Moliterno; Rony Mathew; Rangolee Arora; Dhananjay Deo; J S Hiremath; N V Deshpande; Aziz Khan; Jacob Joseph; Debabrata Mukherjee
Optimal platelet inhibition in patients undergoing PCI: data from the Multicenter Registry of High-Risk Percutaneous Coronary Intervention and Adequate Platelet Inhibition (MR PCI) study.
American heart journal 2007;154(2):344.e1-5.
2007: David J Moliterno; Charles L Campbell
Unraveling questions surrounding clopidogrel resistance and stent thrombosis: one less snag.
Journal of the American College of Cardiology 2007;49(24):2318-9.
2007: James T Dove; David J Moliterno; W Douglas Weaver; Marc E Shelton
President's page: drug-eluting stents in contemporary practice--a call for a real-world, open-entry, device-tracking registry.
Journal of the American College of Cardiology 2007;49(22):2223-6.
2007: Cindy L Grines; Robert O Bonow; Donald E Casey; Timothy J Gardner; Peter B Lockhart; David J Moliterno; Patrick O'Gara; Patrick Whitlow
Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians.
Journal of the American Dental Association (1939) 2007;138(5):652-5.
2007: David J Moliterno
Restenosis following thin-strut bare-metal stents versus thick-strut drug-eluting stents.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2007;69(6):799-800.
2007: David J Moliterno
The challenge of quantifying exceedingly rare occurrences: we can only see what we see.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2007;69(5):719-20.
2007: Adrián V Hernández; Cynthia M Westerhout; Ewout W Steyerberg; John Ioannidis; Hector BUENO; Harvey White; Pierre Theroux; David J Moliterno; Paul W Armstrong; Robert M Califf; Lars Wallentin; Maarten L Simoons; eric boersma
Effects of platelet glycoprotein IIb/IIIa receptor blockers in non-ST segment elevation acute coronary syndromes: benefit and harm in different age subgroups.
Heart (British Cardiac Society) 2007;93(4):450-5.
2007: Mehdi H Shishehbor; Michael Lauer; Inder M Singh; Derek P Chew; Juhana Karha; Sorin J Brener; David J Moliterno; Stephen G Ellis; Eric J Topol; Deepak L Bhatt
In unstable angina or non-ST-segment acute coronary syndrome, should patients with multivessel coronary artery disease undergo multivessel or culprit-only stenting?
Journal of the American College of Cardiology 2007;49(8):849-54.
2007: Cindy L Grines; Robert O Bonow; Donald E Casey; Timothy J Gardner; Peter B Lockhart; David J Moliterno; Patrick O'Gara; Patrick Whitlow
Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2007;69(3):334-40.
2007: Cindy L Grines; Robert O Bonow; Donald E Casey; Timothy J Gardner; Peter B Lockhart; David J Moliterno; Patrick O'Gara; Patrick Whitlow
Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians.
Journal of the American College of Cardiology 2007;49(6):734-9.
2007: Cindy L Grines; Robert O Bonow; Donald E Casey; Timothy J Gardner; Peter B Lockhart; David J Moliterno; Patrick O'Gara; Patrick Whitlow
Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians.
Circulation 2007;115(6):813-8.
2007: Debabrata Mukherjee; David J Moliterno
The timely coupling of mechanical revascularization following thrombolysis for myocardial infarction.
Cardiology 2007;107(4):337-9.
2006: Cynthia M Westerhout; Adrián V Hernández; Ewout W Steyerberg; Hector BUENO; Harvey White; Pierre Théroux; David J Moliterno; Paul W Armstrong; Robert M Califf; Lars Wallentin; Maarten L Simoons; eric boersma
Predictors of stroke within 30 days in patients with non-ST-segment elevation acute coronary syndromes.
European heart journal 2006;27(24):2956-61.
2006: David J Moliterno
Randomized trial versus registry data--comparing apples and ORCHIDs.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2006;68(5):669-70.
2006: Jacqueline Saw; Deepak L Bhatt; David J Moliterno; Sorin J Brener; Steven R Steinhubl; A Michael Lincoff; James E Tcheng; Robert A Harrington; Maarten L Simoons; TingFei Hu; Mobeen A Sheikh; Dean J Kereiakes; Eric J Topol
The influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials.
Journal of the American College of Cardiology 2006;48(8):1567-72.
2006: Pranab Das; David J Moliterno; Richard Charnigo; Debabrata Mukherjee; Steven R Steinhubl; J Darrell Sneed; David C Booth; Khaled M Ziada
Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization.
The Journal of invasive cardiology 2006;18(9):405-8.
2006: David J Moliterno
Imminent extinction of brachy(saurus)therapy for the treatment of in-stent restenosis.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2006;68(3):349-51.
2006: Hussam Hamdalla; David J Moliterno
Clopidogrel in ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention.
Expert opinion on pharmacotherapy 2006;7(12):1669-73.
2006: Pranab Das; Khaled M Ziada; Steven R Steinhubl; David J Moliterno; Hussam Hamdalla; Joseph Jozic; Debabrata Mukherjee
Heparin-induced thrombocytopenia and cardiovascular diseases.
American heart journal 2006;152(1):19-26.
2006: Karen P Alexander; L Kristin Newby; Manjushri Bhapkar; Harvey D White; Judith S Hochman; Matthias E Pfisterer; David J Moliterno; eric peterson; Frans Van de Werf; Paul W Armstrong; Robert M Califf
International variation in invasive care of the elderly with acute coronary syndromes.
European heart journal 2006;27(13):1558-64.
2006: Mehdi H Shishehbor; Eric J Topol; Debabrata Mukherjee; Tingfei Hu; David J Cohen; Gregg W Stone; Rick McClure; Marco Roffi; David J Moliterno
Outcome of multivessel coronary intervention in the contemporary percutaneous revascularization era.
The American journal of cardiology 2006;97(11):1585-90.
2006: Jack L Martin; Gang Jia; Seth S Martin; Timothy A Shapiro; Howard C Herrmann; Peter M DiBattiste; Eric J Topol; David J Moliterno
The relationship of obesity to ischemic outcomes following coronary stent placement in contemporary practice.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2006;67(4):563-70.
2006: Debabrata Mukherjee; David J Moliterno
Brachytherapy for in-stent restenosis: a distant second choice to drug-eluting stent placement.
JAMA : the journal of the American Medical Association 2006;295(11):1307-9.
2006: Sunil V Rao; Kristi O'Grady; Karen S Pieper; Christopher B Granger; L Kristin Newby; Kenneth W Mahaffey; David J Moliterno; A Michael Lincoff; Paul W Armstrong; Frans Van de Werf; Robert M Califf; Robert A Harrington
A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes.
Journal of the American College of Cardiology 2006;47(4):809-16.
2005: Debabrata Mukherjee; Eric J Topol; Michel E Bertrand; Steen Dalby Kristensen; Howard C Herrmann; Franz-Josef Neumann; Steven J Yakubov; Jean-Pierre Bassand; Rick R McClure; Gregg W Stone; Diego Ardissino; David J Moliterno
Mortality at 1 year for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularization: do tirofiban and ReoPro give similar efficacy outcomes at trial 1-year follow-up.
European heart journal 2005;26(23):2524-8.
2005: Donal N Reddan; Lynda Szczech; Manjushri Bhapkar; David J Moliterno; Robert M Califf; Erik Ohman; Peter B Berger; Judith S Hochman; Frans Van de Werf; Robert A Harrington; L Kristin Newby
Renal function, concomitant medication use and outcomes following acute coronary syndromes.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005;20(10):2105-12.
2005: David J Moliterno; Steven R Steinhubl
Clopidogrel for percutaneous coronary revascularization: time for more pretreatment, retreatment, or both?
JAMA : the journal of the American Medical Association 2005;294(10):1271-3.
2005: Michael S Chen; Deepak L Bhatt; Derek P Chew; David J Moliterno; Stephen G Ellis; Eric J Topol
Outcomes in African Americans and whites after percutaneous coronary intervention.
The American journal of medicine 2005;118(9):1019-25.
2005: L Todd Justice; Kent W Dauterman; Nicholas G Smedira; David J Moliterno
Left main dissection and thrombosis in a young athlete.
Cardiology in review 2005;13(5):260-2.
2005: David J Moliterno
Healing Achilles--sirolimus versus paclitaxel.
The New England journal of medicine 2005;353(7):724-7.
2005: Steven R Steinhubl; Richard Charnigo; David J Moliterno
Resistance to antiplatelet resistance is it justified?
Journal of the American College of Cardiology 2005;45(11):1757-8.
2005: Olga S Gurjeva; Matthew T Roe; Sabina A Murphy; David J Moliterno; Christopher P Cannon
Unfortunate impact of age on the management and outcomes of unstable angina and non-ST elevation myocardial infarction (The GUARANTEE Registry).
Critical pathways in cardiology 2005;4(2):81-7.
2005: Rajendra H Mehta; Robert M Califf; Jyotsna Garg; Karen S Pieper; John H Alexander; David J Moliterno; Frans Van de Werf; Erik Ohman; Harvey D White; Eric J Topol; Christopher B Granger
Association of height with outcomes in patients with acute myocardial infarction receiving reperfusion therapy.
The American journal of cardiology 2005;95(11):1371-5.
2005: Peter B Berger; Patricia J M Best; Eric J Topol; Jennifer White; Peter M DiBattiste; Albert W Chan; Steen Dalby Kristensen; Howard C Herrmann; David J Moliterno
The relation of renal function to ischemic and bleeding outcomes with 2 different glycoprotein IIb/IIIa inhibitors: the do Tirofiban and ReoPro Give Similar Efficacy Outcome (TARGET) trial.
American heart journal 2005;149(5):869-75.
2005: Pranab Das; David J Moliterno
Enoxaparin in clinical practice and clinical trials of non-ST-elevation Acute Coronary Syndrome (NSTE-ACS).
Journal of thrombosis and thrombolysis 2005;19(2):105-13.
2005: Mardi Gomberg-Maitland; Sabina A Murphy; David J Moliterno; Christopher P Cannon
Are we appropriately triaging patients with unstable angina?
American heart journal 2005;149(4):613-8.
2005: Victor A Ferraris; Suellen P Ferraris; David J Moliterno; Phillip C Camp; Jeanine M Walenga; Harry L Messmore; Walter P Jeske; Fred H Edwards; David Royston; David M Shahian; Eric Peterson; Charles R Bridges; George J Despotis
The Society of Thoracic Surgeons practice guideline series: aspirin and other antiplatelet agents during operative coronary revascularization (executive summary).
The Annals of thoracic surgery 2005;79(4):1454-61.
2005: Jose E Exaire; James E Tcheng; Dean J Kereiakes; Neal S Kleiman; Robert J Applegate; David J Moliterno
Closure devices and vascular complications among percutaneous coronary intervention patients receiving enoxaparin, glycoprotein IIb/IIIa inhibitors, and clopidogrel.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2005;64(3):369-72.
2005: Steven R Steinhubl; David J Moliterno
The role of the platelet in the pathogenesis of atherothrombosis.
American journal of cardiovascular drugs : drugs, devices, and other interventions 2005;5(6):399-408.
2005: Marino Labinaz; Jasmine Mathias; Karen S Pieper; Christopher B Granger; A Michael Lincoff; David J Moliterno; Frans Van de Werf; R John Simes; Harvey D White; Maarten L Simoons; Robert M Califf; Eric J Topol; Paul W Armstrong; Robert A Harrington
Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trials.
European heart journal 2005;26(2):128-36.
2004: Sunil V Rao; James G Jollis; Robert A Harrington; Christopher B Granger; L Kristin Newby; Paul W Armstrong; David J Moliterno; Lauren Lindblad; Karen S Pieper; Eric J Topol; Jonathan S Stamler; Robert M Califf
Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes.
JAMA : the journal of the American Medical Association 2004;292(13):1555-62.
2004: Stephen G Ellis; Christopher T Bajzer; Deepak L Bhatt; Sorin J Brener; Patrick L Whitlow; A Michael Lincoff; David J Moliterno; Russell E Raymond; E Murat Tuzcu; Irving Franco; Sandra Dushman-Ellis; Katherine J Lander; Jakob P Schneider; Eric J Topol
Real-world bare metal stenting: identification of patients at low or very low risk of 9-month coronary revascularization.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2004;63(2):135-40.
2004: Craig R Asher; David J Moliterno; Manjushri Bhapkar; Darren K McGuire; Sunil V Rao; David R Holmes; L Kristin Newby; Eric R Bates; Eric J Topol
Association of race with complications and prognosis following acute coronary syndromes.
The American journal of cardiology 2004;94(6):792-4.
2004: Jacqueline Saw; Eric J Topol; Steven R Steinhubl; Danielle Brennan; Peter B Berger; David J Moliterno
Comparison of long-term usefulness of clopidogrel therapy after the first percutaneous coronary intervention or coronary artery bypass grafting versus that after the second or repeat intervention.
The American journal of cardiology 2004;94(5):623-5.
2004: Sorin J Brener; David J Moliterno; A Michael Lincoff; Steven R Steinhubl; Kathy Wolski; Eric J Topol
Relationship between activated clotting time and ischemic or hemorrhagic complications: analysis of 4 recent randomized clinical trials of percutaneous coronary intervention.
Circulation 2004;110(8):994-8.
2004: Samir R Kapadia; David J Moliterno
Did we enjoy the debate but forget the patient?
Journal of the American College of Cardiology 2004;44(4):775-7.
2004: Deepak P Vivekananthan; Deepak L Bhatt; Derek P Chew; Frank J Zidar; Albert W Chan; David J Moliterno; Stephen G Ellis; Eric J Topol
Effect of clopidogrel pretreatment on periprocedural rise in C-reactive protein after percutaneous coronary intervention.
The American journal of cardiology 2004;94(3):358-60.
2004: Pranab Das; David J Moliterno
Fractionating heparins and their clinical trial data--something for everyone.
JAMA : the journal of the American Medical Association 2004;292(1):101-3.
2004: Piera Angelica Merlini; Marco Rossi; Alessandro Menozzi; Silvia Buratti; Danielle M Brennan; David J Moliterno; Eric J Topol; Diego Ardissino
Thrombocytopenia caused by abciximab or tirofiban and its association with clinical outcome in patients undergoing coronary stenting.
Circulation 2004;109(18):2203-6.
2004: Matthew T Roe; Kenneth W Mahaffey; Rakhi Kilaru; John H Alexander; K Martijn Akkerhuis; Maarten L Simoons; Robert A Harrington; Barbara E Tardiff; Christopher B Granger; Erik Ohman; David J Moliterno; A Michael Lincoff; Paul W Armstrong; Frans Van de Werf; Robert M Califf; Eric J Topol
Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes.
European heart journal 2004;25(4):313-21.
2004: Darren K McGuire; L Kristin Newby; Manjushri Bhapkar; David J Moliterno; Judith S Hochman; Werner W Klein; W Douglas Weaver; Matthias Pfisterer; Ramón Corbalán; Mikael Dellborg; Christopher B Granger; Frans Van de Werf; Eric J Topol; Robert M Califf
Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromes.
American heart journal 2004;147(2):246-52.
2004: David S Lee; Deepak L Bhatt; David J Moliterno; W Frank Peacock; Stephen G Ellis; Eric J Topol
The combination of enoxaparin, glycoprotein IIb/IIIa inhibitors and an early invasive approach among acute coronary syndrome patients.
The Journal of invasive cardiology 2004;16(2):46-51.
2004: Qing Wang; Shaoqi Rao; Gong-Qing Shen; Lin Li; David J Moliterno; L Kristin Newby; William J Rogers; Ruth Cannata; Erich Zirzow; Robert C Elston; Eric J Topol
Premature myocardial infarction novel susceptibility locus on chromosome 1P34-36 identified by genomewide linkage analysis.
American journal of human genetics 2004;74(2):262-71.
2004: Ivan P Casserly; Dean J Kereiakes; William A Gray; Paul H Gibson; Michael A Lauer; Joel P Reginelli; David J Moliterno
Point-of-care ecarin clotting time versus activated clotting time in correlation with bivalirudin concentration.
Thrombosis research 2004;113(2):115-21.
2004: Jose E Exaire; Harold L Dauerman; Eric J Topol; James C Blankenship; Kathy Wolski; Russell E Raymond; Eric A Cohen; David J Moliterno
Triple antiplatelet therapy does not increase femoral access bleeding with vascular closure devices.
American heart journal 2004;147(1):31-4.
2003: Sorin J Brener; Deepak L Bhatt; David J Moliterno; Jakob P Schneider; Stephen G Ellis; Eric J Topol
Revisiting optimal anticoagulation with unfractionated heparin during coronary stent implantation.
The American journal of cardiology 2003;92(12):1468-71.
2003: Debabrata Mukherjee; Amy Hsu; David J Moliterno; A Michael Lincoff; Marlene Goormastic; Eric J Topol
Risk factors for premature coronary artery disease and determinants of adverse outcomes after revascularization in patients < or =40 years old.
The American journal of cardiology 2003;92(12):1465-7.
2003: L Kristin Newby; Manjushri Bhapkar; Harvey D White; David J Moliterno; Nancy M Allen LaPointe; David E Kandzari; Freek W A Verheugt; Judith M Kramer; Paul W Armstrong; Robert M Califf
Aspirin use post-acute coronary syndromes: intolerance, bleeding and discontinuation.
Journal of thrombosis and thrombolysis 2003;16(3):119-28.
2003: Jeanette J McCarthy; Joanne Meyer; David J Moliterno; L Kristin Newby; William J Rogers; Eric J Topol
Evidence for substantial effect modification by gender in a large-scale genetic association study of the metabolic syndrome among coronary heart disease patients.
Human genetics 2003;114(1):87-98.
2003: Umesh N Khot; Gang Jia; David J Moliterno; A Michael Lincoff; Monica B Khot; Robert A Harrington; Eric J Topol
Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes: the enduring value of Killip classification.
JAMA : the journal of the American Medical Association 2003;290(16):2174-81.
2003: Albert W Chan; David J Moliterno; Peter B Berger; Gregg W Stone; Peter M DiBattiste; Steven L Yakubov; Shelly K Sapp; Kathy Wolski; Deepak L Bhatt; Eric J Topol
Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: results from the Do Tirofiban and ReoProGive Similar Efficacy Outcome Trial (TARGET).
Journal of the American College of Cardiology 2003;42(7):1188-95.
2003: David J Moliterno; James Hermiller; Dean J Kereiakes; Eric Yow; Robert J Applegate; Gregory A Braden; Eric J Dippel; Mark I Furman; Cindy L Grines; Neal S Kleiman; Glenn N Levine; Tift Mann; Ravi N Nair; Ronald A Stine; Steven J Yacubov; James E Tcheng
A novel point-of-care enoxaparin monitor for use during percutaneous coronary intervention. Results of the Evaluating Enoxaparin Clotting Times (ELECT) Study.
Journal of the American College of Cardiology 2003;42(6):1132-9.
2003: Mitchell J Ross; Howard C Herrmann; David J Moliterno; James C Blankenship; Laura A Demopoulos; Peter M DiBattiste; Stephen G Ellis; Ziyad Ghazzal; Jack L Martin; Jennifer White; Eric J Topol
Angiographic variables predict increased risk for adverse ischemic events after coronary stenting with glycoprotein IIb/IIIa inhibition: results from the TARGET trial.
Journal of the American College of Cardiology 2003;42(6):981-8.
2003: Michael H Yen; Deepak L Bhatt; Derek P Chew; Robert A Harrington; L Kristin Newby; Diego Ardissino; Frans Van de Werf; Jennifer A White; David J Moliterno; Eric J Topol
Association between admission white blood cell count and one-year mortality in patients with acute coronary syndromes.
The American journal of medicine 2003;115(4):318-21.
2003: Paul Schoenhagen; E Murat Tuzcu; Arthur E Stillman; David J Moliterno; Sandra S Halliburton; Stacie A Kuzmiak; Jane M Kasper; William A Magyar; Michael L Lieber; Steven E Nissen; Richard D White
Non-invasive assessment of plaque morphology and remodeling in mildly stenotic coronary segments: comparison of 16-slice computed tomography and intravascular ultrasound.
Coronary artery disease 2003;14(6):459-62.
2003: John H Chiu; Eric J Topol; Patrick L Whitlow; Amy P Hsu; E Murat Tuzcu; Irving Franco; David J Moliterno
Peripheral vascular disease and one-year mortality following percutaneous coronary revascularization.
The American journal of cardiology 2003;92(5):582-3.
2003: Thaddeus R Tolleson; L Kristin Newby; Robert A Harrington; Manjushri Bhapkar; Freek W A Verheugt; Peter B Berger; David J Moliterno; Harvey D White; Erik Ohman; Frans Van de Werf; Eric J Topol; Robert M Califf
Frequency of stent thrombosis after acute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trials).
The American journal of cardiology 2003;92(3):330-3.
2003: Jacqueline Saw; David J Moliterno
Contemporary use of antiplatelet therapies in percutaneous coronary interventions.
Coronary artery disease 2003;14(5):373-80.
2003: Ivan P Casserly; Eric J Topol; Gang Jia; Richard A Lange; Christian Hamm; Bernhard Meier; Peter M DiBattiste; Nasser Lakkis; Derek P Chew; Gregg W Stone; David J Cohen; David J Moliterno
Effect of abciximab versus tirofiban on activated clotting time during percutaneous intervention and its relation to clinical outcomes--observations from the TARGET trial.
The American journal of cardiology 2003;92(2):125-9.
2003: Leslie Cho; Kandice Kottke-Marchant; A Michael Lincoff; Marco Roffi; Joel P Reginelli; Theresa Kaldus; David J Moliterno
Correlation of point-of-care ecarin clotting time versus activated clotting time with bivalirudin concentrations.
The American journal of cardiology 2003;91(9):1110-3.
2003: David J Moliterno; Marc S Penn
Angioplasty, inflammation, and antiplatelet agents.
American heart journal 2003;145(4):563-6.
2003: Leslie Cho; Derek P Chew; David J Moliterno; Marco Roffi; Stephen G Ellis; Irving Franco; Christopher T Bajzer; Deepak L Bhatt; Khosrow Dorosti; Conrad Simpfendorder; Murat Tuzcu; Jay S Yadav; Sorin J Brener; Russell E Raymond; Patrick L Whitlow; Eric J Topol; A Michael Lincoff
Safe and efficacious use of bivalirudin for percutaneous coronary intervention with adjunctive platelet glycoprotein IIb/IIIa receptor inhibition.
The American journal of cardiology 2003;91(6):742-3.
2003: Sorin J Brener; Mark G Midei; Dean Nukta; Dean J Kereiakes; David G Rizik; Donel Murphy; Danielle Brennan; David J Moliterno
A randomized multicenter trial comparing a new, low-pressure versus a conventional coronary stent: primary results from the CONSERVE trial.
The Journal of invasive cardiology 2003;15(3):128-32.
2003: David J Moliterno; Albert W Chan
Glycoprotein IIb/IIIa inhibition in early intent-to-stent treatment of acute coronary syndromes: EPISTENT, ADMIRAL, CADILLAC, and TARGET.
Journal of the American College of Cardiology 2003;41(4 Suppl S):49S-54S.
2003: Martin J Quinn; David J Moliterno
Diabetes and percutaneous coronary intervention: the sweet smell of success?
American heart journal 2003;145(2):203-5.
2003: Jacqueline Saw; Dean J Kereiakes; Kenneth W Mahaffey; Robert J Applegate; Gregory A Braden; Bruce N Brent; Bruce R Brodie; James B Groce; Glenn N Levine; Ferdinand Leya; David J Moliterno
Evaluation of a novel point-of-care enoxaparin monitor with central laboratory anti-Xa levels.
Thrombosis research 2003;112(5-6):301-6.
2002: Debabrata Mukherjee; Kenneth W Mahaffey; David J Moliterno; Robert A Harrington; Jay S Yadav; Karen S Pieper; Dianne Gallup; Christopher Dyke; Matthew T Roe; Lisa G Berdan; Michael Lauer; Matti Mänttäri; Harvey D White; Robert M Califf; Eric J Topol
Promise of combined low-molecular-weight heparin and platelet glycoprotein IIb/IIIa inhibition: results from Platelet IIb/IIIa Antagonist for the Reduction of Acute coronary syndrome events in a Global Organization Network B (PARAGON B).
American heart journal 2002;144(6):995-1002.
2002: Debabrata Mukherjee; Hitinder S Gurm; W H Wilson Tang; Marco Roffi; Kathy Wolski; David J Moliterno; Victor Guetta; Diego Ardissinio; Christopher Bode; Gabriel Steg; A Michael Lincoff; Eric J Topol
Outcome of acute myocardial infarction in patients with prior coronary artery bypass grafting treated with combination reduced fibrinolytic therapy and abciximab.
The American journal of cardiology 2002;90(11):1198-203.
2002: Dean J Kereiakes; Gilles Montalescot; Elliott M Antman; Marc Cohen; Harald Darius; James J Ferguson; Cindy L Grines; Karl R Karsch; Neal S Kleiman; David J Moliterno; Philippe Gabriel STEG; Paul Teirstein; Frans Van de Werf; Lars Wallentin
Low-molecular-weight heparin therapy for non-ST-elevation acute coronary syndromes and during percutaneous coronary intervention: an expert consensus.
American heart journal 2002;144(4):615-24.
2002: Benjamin M Scirica; Christopher P Cannon; C Michael Gibson; Sabina A Murphy; David J Moliterno; H Vernon Anderson; FV Aguirre; Christopher B Granger; Costas T Lambrew; LeRoy E Rabbani; Shelly K Sapp; Joan E Booth; James J Ferguson; Eugene Braunwald
Assessing the effect of publication of clinical guidelines on the management of unstable angina and non-ST elevation myocardial infarction in the TIMI III (1990-1993) and the GUARANTEE (1995-1996) Registries.
Critical pathways in cardiology 2002;1(3):150-8.
2002: Marco Roffi; Derek P Chew; Debabrata Mukherjee; Deepak L Bhatt; J A White; David J Moliterno; Christopher Heeschen; C W Hamm; Mark A Robbins; Neal S Kleiman; P Théroux; Harvey D White; Eric J Topol
Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes. Gradient of benefit related to the revascularization strategy.
European heart journal 2002;23(18):1441-8.
2002: Albert W Chan; Martin J Quinn; Deepak L Bhatt; Derek P Chew; David J Moliterno; Eric J Topol; Stephen G Ellis
Mortality benefit of beta-blockade after successful elective percutaneous coronary intervention.
Journal of the American College of Cardiology 2002;40(4):669-75.
2002: David J Moliterno; Steven J Yakubov; Peter M DiBattiste; Howard C Herrmann; Gregg W Stone; Carlos Macaya; Franz-Josef Neumann; Diego Ardissino; Jean-Pierre Bassand; Lynn Borzi; Alan C Yeung; Katherine A Harris; Laura A Demopoulos; Eric J Topol
Outcomes at 6 months for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularisation with stent placement: the TARGET follow-up study.
Lancet 2002;360(9330):355-60.
2002: L Kristin Newby; Robert A Harrington; Manjushri Bhapkar; Frans Van de Werf; Judith S Hochman; Christopher B Granger; R John Simes; Catherine G Davis; Eric J Topol; Robert M Califf; David J Moliterno
An automated strategy for bedside aPTT determination and unfractionated heparin infusion adjustment in acute coronary syndromes: insights from PARAGON A.
Journal of thrombosis and thrombolysis 2002;14(1):33-42.
2002: Eric Boersma; Robert A Harrington; David J Moliterno; Harvey White; Maarten L Simoons
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
Lancet 2002;360(9329):342-3.
2002: Sana M Al-Khatib; Christopher B Granger; Yao Huang; Kerry L Lee; Robert M Califf; Maarten L Simoons; Paul W Armstrong; Frans Van de Werf; Harvey D White; R John Simes; David J Moliterno; Eric J Topol; Robert A Harrington
Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes.
Circulation 2002;106(3):309-12.
2002: Leslie Cho; Nicholas G Smedira; Richard D White; David J Moliterno
Giant saphenous vein graft aneurysm.
Cardiology in review 2002;10(4):247-8.
2002: L Kristin Newby; Arni Kristinsson; Manjushri Bhapkar; Philip E Aylward; Alexios P Dimas; Werner W Klein; Darren K McGuire; David J Moliterno; Freek W A Verheugt; W Douglas Weaver; Robert M Califf
Early statin initiation and outcomes in patients with acute coronary syndromes.
JAMA : the journal of the American Medical Association 2002;287(23):3087-95.
2002: Marco Roffi; David J Moliterno; Bernhard Meier; Eric Randall Powers; Cindy L Grines; Peter M DiBattiste; Howard C Herrmann; Michel Bertrand; Katherine E Harris; Laura A Demopoulos; Eric J Topol
Impact of different platelet glycoprotein IIb/IIIa receptor inhibitors among diabetic patients undergoing percutaneous coronary intervention: : Do Tirofiban and ReoPro Give Similar Efficacy Outcomes Trial (TARGET) 1-year follow-up.
Circulation 2002;105(23):2730-6.
2002: Warren J Cantor; L Kristin Newby; Robert H Christenson; Robert H Tuttle; Vic Hasselblad; Paul W Armstrong; David J Moliterno; Robert M Califf; Eric J Topol; Erik Ohman
Prognostic significance of elevated troponin I after percutaneous coronary intervention.
Journal of the American College of Cardiology 2002;39(11):1738-44.
2002: Gregg W Stone; David J Moliterno; Michel Bertrand; Franz-Josef Neumann; Howard C Herrmann; Eric Randall Powers; Cindy L Grines; Jeffrey W Moses; David J Cohen; Eric A Cohen; Marc Cohen; Kathy Wolski; Peter M DiBattiste; Eric J Topol
Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET Trial.
Circulation 2002;105(20):2347-54.
2002: Deepak P Vivekananthan; Vasant B Patel; David J Moliterno
Glycoprotein IIb/IIIa antagonism and fibrinolytic therapy for acute myocardial infarction.
Journal of interventional cardiology 2002;15(2):131-9.
2002: Guy L Wheeler; Gregory A Braden; Steven R Steinhubl; Dean J Kereiakes; Kandice Kottke-Marchant; Alan D Michelson; Mark I Furman; Michele N Mueller; David J Moliterno; David C Sane
The Ultegra rapid platelet-function assay: comparison to standard platelet function assays in patients undergoing percutaneous coronary intervention with abciximab therapy.
American heart journal 2002;143(4):602-11.
2002: Albert W Chan; Deepak L Bhatt; Derek P Chew; Martin J Quinn; David J Moliterno; Eric J Topol; Stephen G Ellis
Early and sustained survival benefit associated with statin therapy at the time of percutaneous coronary intervention.
Circulation 2002;105(6):691-6.
2002: Deepak P Vivekananthan; David J Moliterno
Glycoprotein IIb/IIIa combination therapy in acute myocardial infarction: tailoring therapies to optimize outcome.
Journal of thrombosis and thrombolysis 2002;13(1):35-9.
2002: Derek P Chew; David J Moliterno
Managing unstable angina in high-risk patients.
The Journal of invasive cardiology 2002;14 Suppl A():31A-48A.
2002: Derek P Chew; David J Moliterno; Howard C Herrmann
Present and potential future paradigms for the treatment of ST-segment elevation acute myocardial infarction.
The Journal of invasive cardiology 2002;14 Suppl A():3A-20A.
2002: eric boersma; Robert A Harrington; David J Moliterno; Harvey White; Pierre Théroux; Frans Van de Werf; Anneke de Torbal; Paul W Armstrong; Lars Wallentin; Robert G Wilcox; R John Simes; Robert M Califf; Eric J Topol; Maarten L Simoons
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials.
Lancet 2002;359(9302):189-98.
2002: Albert W Chan; Derek P Chew; Deepak L Bhatt; David J Moliterno; Eric J Topol; Stephen G Ellis
Long-term mortality benefit with the combination of stents and abciximab for cardiogenic shock complicating acute myocardial infarction.
The American journal of cardiology 2002;89(2):132-6.
2001: Marco Roffi; Derek P Chew; Debabrata Mukherjee; Deepak L Bhatt; J A White; Christopher Heeschen; C W Hamm; David J Moliterno; Robert M Califf; Harvey D White; Neal S Kleiman; P Théroux; Eric J Topol
Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes.
Circulation 2001;104(23):2767-71.
2001: N K Sekaran; David J Moliterno; J J Ferguson; Nathan R Every; H V Anderson; FV Aguirre; William J French; Shelly K Sapp; Joan E Booth; Christopher B Granger; Christopher P Cannon
"Hot" unstable angina--is it worse than subacute unstable angina? Results from the GUARANTEE Registry.
Journal of thrombosis and thrombolysis 2001;12(3):207-16.
2001: D P Chew; David J Moliterno
GP IIb/IIIa inhibitors in coronary artery disease management: what the latest trials tell us.
Cleveland Clinic journal of medicine 2001;68(12):1017-23.
2001: Stephen G Ellis; Sorin J Brener; A Michael Lincoff; David J Moliterno; Patrick L Whitlow; Jakob P Schneider; Eric J Topol
beta-blockers before percutaneous coronary intervention do not attenuate postprocedural creatine kinase isoenzyme rise.
Circulation 2001;104(22):2685-8.
2001: Eric J Topol; J McCarthy; S Gabriel; David J Moliterno; W J Rogers; L K Newby; M Freedman; J Metivier; R Cannata; C J O'Donnell; Kandice Kottke-Marchant; Gurunathan Murugesan; Edward F Plow; Olga I Stenina; G Q Daley
Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction.
Circulation 2001;104(22):2641-4.
2001: A W Chan; David J Moliterno
In-stent restenosis: update on intracoronary radiotherapy.
Cleveland Clinic journal of medicine 2001;68(9):796-803.
2001: J M Estess; David J Moliterno
Thrombolytic therapy for acute myocardial infarction.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2001;53(4):489-98.
2001: Eric J Topol; David J Moliterno; Howard C Herrmann; Eric Randall Powers; Cindy L Grines; D J Cohen; Eric A Cohen; M Bertrand; Franz-Josef Neumann; Gregg W Stone; Peter M DiBattiste; Laura A Demopoulos
Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization.
The New England journal of medicine 2001;344(25):1888-94.
2001: Debabrata Mukherjee; D P Chew; M Robbins; Jay S Yadav; R E Raymond; David J Moliterno
Clinical application of procedural platelet monitoring during percutaneous coronary intervention among patients at increased bleeding risk.
Journal of thrombosis and thrombolysis 2001;11(2):151-4.
2001: Leslie Cho; Deepak L Bhatt; Kathy Wolski; M Lincoff; Eric J Topol; David J Moliterno
Effect of smoking status and abciximab use on outcome after percutaneous coronary revascularization: Pooled analysis from EPIC, EPILOG, and EPISTENT.
American heart journal 2001;141(4):599-602.
2001: Derek P Chew; Deepak L Bhatt; A Michael Lincoff; David J Moliterno; Sorin J Brener; Kathy Wolski; Eric J Topol
Defining the optimal activated clotting time during percutaneous coronary intervention: aggregate results from 6 randomized, controlled trials.
Circulation 2001;103(7):961-6.
2000: Debabrata Mukherjee; David J Moliterno
Monitoring antiplatelet therapy: What is the best method?
Clinical pharmacokinetics 2000;39(6):445-58.
2000: Derek P Chew; David J Moliterno
A critical appraisal of platelet glycoprotein IIb/IIIa inhibition.
Journal of the American College of Cardiology 2000;36(7):2028-35.
2000: David J Moliterno; Debabrata Mukherjee
Applications of monitoring platelet glycoprotein IIb/IIIa antagonism and low molecular weight heparins in cardiovascular medicine.
American heart journal 2000;140(6 Suppl):S136-42.
2000: Howard C Herrmann; David J Moliterno; Erik Ohman; Amanda L Stebbins; C Bode; A Betriu; F Forycki; J S Miklin; W B Bachinsky; A Michael Lincoff; Robert M Califf; Eric J Topol
Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: results from the SPEED (GUSTO-4 Pilot) Trial.
Journal of the American College of Cardiology 2000;36(5):1489-96.
2000: Debabrata Mukherjee; Joel P Reginelli; David J Moliterno; Jay S Yadav; Jakob P Schneider; Russell E Raymond; Patrick L Whitlow; Irving Franco; Eric J Topol; Stephen G Ellis
Unexpected mortality reduction with abciximab for in-stent restenosis.
The Journal of invasive cardiology 2000;12(11):540-4.
2000: Eric J Topol; Erik Ohman; Paul W Armstrong; Robert Wilcox; Allan Michael Skene; Philip E Aylward; R John Simes; A Dalby; Amadeo Betriu; C Bode; Harvey D White; Judith S Hochman; H Emanuelson; A Vahanian; Shelly K Sapp; Amanda L Stebbins; David J Moliterno; Robert M Califf
Survival outcomes 1 year after reperfusion therapy with either alteplase or reteplase for acute myocardial infarction: results from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) III Trial.
Circulation 2000;102(15):1761-5.
2000: Fernando A Cura; Deepak L Bhatt; A Michael Lincoff; Samir R Kapadia; Philippe L L'Allier; Khaled M Ziada; Kathy Wolski; David J Moliterno; Sorin J Brener; Stephen G Ellis; Eric J Topol
Pronounced benefit of coronary stenting and adjunctive platelet glycoprotein IIb/IIIa inhibition in complex atherosclerotic lesions.
Circulation 2000;102(1):28-34.
2000: Debabrata Mukherjee; David J Moliterno
Achieving tissue-level perfusion in the setting of acute myocardial infarction.
The American journal of cardiology 2000;85(8A):39C-46C.
2000: Debabrata Mukherjee; David J Moliterno
Applications of anti-platelet monitoring in catheterization laboratory.
Journal of thrombosis and thrombolysis 2000;9(3):293-301.
2000: I P Casserly; David J Moliterno
Platelet glycoprotein IIb/IIIa receptor antagonists.
Expert opinion on pharmacotherapy 2000;1(3):419-33.
2000: V B Patel; David J Moliterno
Glycoprotein IIb/IIIa antagonist and fibrinolytic agents: new therapeutic regimen for acute myocardial infarction.
The Journal of invasive cardiology 2000;12 Suppl B():8B-15B.
2000: Sorin J Brener; Stephen G Ellis; Shelly K Sapp; A Betriu; C B Granger; JE Burchenal; David J Moliterno; Robert M Califf; Eric J Topol
Predictors of death and reinfarction at 30 days after primary angioplasty: the GUSTO IIb and RAPPORT trials.
American heart journal 2000;139(3):476-81.
1999: Craig R Asher; Eric J Topol; David J Moliterno
Insights into the pathophysiology of atherosclerosis and prognosis of black Americans with acute coronary syndromes.
American heart journal 1999;138(6 Pt 1):1073-81.
1999: Benjamin M Scirica; David J Moliterno; Nathan R Every; H V Anderson; FV Aguirre; Christopher B Granger; Costas T Lambrew; L E Rabbani; Shelly K Sapp; Joan E Booth; James J Ferguson; Christopher P Cannon
Racial differences in the management of unstable angina: results from the multicenter GUARANTEE registry.
American heart journal 1999;138(6 Pt 1):1065-72.
1999: Benjamin M Scirica; David J Moliterno; Nathan R Every; H Vernon Anderson; FV Aguirre; Christopher B Granger; Costas T Lambrew; L E Rabbani; A Arnold; Shelly K Sapp; Joan E Booth; James J Ferguson; Christopher P Cannon
Differences between men and women in the management of unstable angina pectoris (The GUARANTEE Registry). The GUARANTEE Investigators.
The American journal of cardiology 1999;84(10):1145-50.
1999: Koon-Hou Mak; David J Moliterno
Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes.
Current cardiology reports 1999;1(3):199-205.
1999: A Michael Lincoff; Robert M Califf; David J Moliterno; Stephen G Ellis; J Ducas; J H Kramer; Neal S Kleiman; Eric A Cohen; Joan E Booth; Shelly K Sapp; CF Cabot; Eric J Topol
Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators.
The New England journal of medicine 1999;341(5):319-27.
1999: M T Roe; David J Moliterno
Emerging treatment of acute coronary syndromes with platelet glycoprotein IIB/IIIA inhibitors.
Journal of thrombosis and thrombolysis 1999;7(3):247-57.
1999: M T Roe; David J Moliterno
Treatment of non-ST-segment-elevation acute coronary syndromes with platelet glycoprotein IIb/IIIa inhibitors: an emergency department perspective.
The Journal of emergency medicine 1999;17(3):581-8.
1999: V B Patel; David J Moliterno
Invasive vs conservative management of non-Q-wave myocardial infarction.
Cleveland Clinic journal of medicine 1999;66(2):100-4.
1998: David F Kong; Robert M Califf; Dave P Miller; David J Moliterno; Harvey D White; Robert A Harrington; James E Tcheng; A Michael Lincoff; Vic Hasselblad; Eric J Topol
Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease.
Circulation 1998;98(25):2829-35.
1998: Steven R Steinhubl; Michael Lauer; Debabrata Mukherjee; David J Moliterno; A Michael Lincoff; Stephen G Ellis; Eric J Topol
The duration of pretreatment with ticlopidine prior to stenting is associated with the risk of procedure-related non-Q-wave myocardial infarctions.
Journal of the American College of Cardiology 1998;32(5):1366-70.
1998: Sorin J Brener; L A Barr; JE Burchenal; S Katz; Barry S George; A A Jones; E D Cohen; P C Gainey; H J White; H B Cheek; J W Moses; David J Moliterno; Mark B Effron; Eric J Topol
Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators.
Circulation 1998;98(8):734-41.
1998: Nathan R Every; Christopher P Cannon; C Granger; David J Moliterno; FV Aguirre; J D Talley; J Booth; Shelly K Sapp; James J Ferguson
Influence of insurance type on the use of procedures, medications and hospital outcome in patients with unstable angina: results from the GUARANTEE Registry. Global Unstable Angina Registry and Treatment Evaluation.
Journal of the American College of Cardiology 1998;32(2):387-92.
1998: M T Roe; David J Moliterno
The EPILOG trial. Abciximab prevents ischemic complications during angioplasty. Evaluation in PTCA to improve Long-Term Outcome with Abciximab GP IIb/IIIa Blockade.
Cleveland Clinic journal of medicine 1998;65(5):267-72.
1997: RC Wallace; Anthony J Furlan; David J Moliterno; Glen H J Stevens; Thomas J Masaryk; John Perl
Basilar artery rethrombosis: successful treatment with platelet glycoprotein IIB/IIIA receptor inhibitor.
AJNR. American journal of neuroradiology 1997;18(7):1257-60.
1997: CC Simpfendorfer; Kandice Kottke-Marchant; M Lowrie; R J Anders; D M Burns; Dave P Miller; C S Cove; A C DeFranco; Stephen G Ellis; David J Moliterno; Russell E Raymond; Joseph M Sutton; Eric J Topol
First chronic platelet glycoprotein IIb/IIIa integrin blockade. A randomized, placebo-controlled pilot study of xemilofiban in unstable angina with percutaneous coronary interventions.
Circulation 1997;96(1):76-81.
1997: Koon-Hou Mak; David J Moliterno; Christopher B Granger; Dave P Miller; Harvey D White; Robert G Wilcox; Robert M Califf; Eric J Topol
Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
Journal of the American College of Cardiology 1997;30(1):171-9.
1997: Steven R Steinhubl; David J Moliterno
Glycoprotein IIb/IIIa receptor antagonists for the treatment of unstable angina.
Heart and vessels 1997;Suppl 12():148-55.
1996: M Gottsauner-Wolf; David J Moliterno; A Michael Lincoff; Eric J Topol
Restenosis--an open file.
Clinical cardiology 1996;19(5):347-56.
1996: Koon-Hou Mak; G Belli; Stephen G Ellis; David J Moliterno
Subacute stent thrombosis: evolving issues and current concepts.
Journal of the American College of Cardiology 1996;27(2):494-503.
1995: David J Moliterno; E V Jokinen; André R Miserez; Richard A Lange; J E Willard; E Boerwinkle; L D Hillis; Helen H Hobbs
No association between plasma lipoprotein(a) concentrations and the presence or absence of coronary atherosclerosis in African-Americans.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(7):850-5.
1995: Steven E Nissen; A C De Franco; E Murat Tuzcu; David J Moliterno
Coronary intravascular ultrasound: diagnostic and interventional applications.
Coronary artery disease 1995;6(5):355-67.
1995: David J Moliterno; Robert M Califf; F V Aguirre; K Anderson; Kristina N Sigmon; HF Weisman; Eric J Topol
Effect of platelet glycoprotein IIb/IIIa integrin blockade on activated clotting time during percutaneous transluminal coronary angioplasty or directional atherectomy (the EPIC trial). Evaluation of c7E3 Fab in the Prevention of Ischemic Complications trial.
The American journal of cardiology 1995;75(8):559-62.
1995: David J Moliterno; J M Elliott
Randomized trials of myocardial revascularization.
Current problems in cardiology 1995;20(3):125-90.
1994: David J Moliterno; Richard A Lange; Robert D Gerard; J E Willard; C Lackner; L David Hillis
Influence of intranasal cocaine on plasma constituents associated with endogenous thrombosis and thrombolysis.
The American journal of medicine 1994;96(6):492-6.
1994: David J Moliterno; J E Willard; Richard A Lange; B H Negus; J D Boehrer; D B Glamann; Charles L Landau; J D Rossen; M D Winniford; L David Hillis
Coronary-artery vasoconstriction induced by cocaine, cigarette smoking, or both.
The New England journal of medicine 1994;330(7):454-9.
1993: G W Taylor; David J Moliterno; L David Hillis
Peripartum myocardial infarction.
American heart journal 1993;126(6):1462-3.
1993: David J Moliterno; Richard A Lange; J E Willard; J D Boehrer; L David Hillis
Surgical restoration of antegrade flow in the occluded infarct artery improves long-term survival in patients with multivessel coronary artery disease.
Coronary artery disease 1993;4(11):995-9.
1993: David J Moliterno; Richard A Lange; Robert S Meidell; J E Willard; C C Leffert; Robert D Gerard; Eric Boerwinkle; Helen H Hobbs; L David Hillis
Relation of plasma lipoprotein(a) to infarct artery patency in survivors of myocardial infarction.
Circulation 1993;88(3):935-40.
1993: J D Boehrer; David J Moliterno; J E Willard; L David Hillis; Richard A Lange
Influence of labetalol on cocaine-induced coronary vasoconstriction in humans.
The American journal of medicine 1993;94(6):608-10.
1992: J D Boehrer; David J Moliterno; J E Willard; R W Snyder; R P Horton; D B Glamann; Richard A Lange; L David Hillis
Hemodynamic effects of intranasal cocaine in humans.
Journal of the American College of Cardiology 1992;20(1):90-3.
1991: W C Brogan; Richard A Lange; A S Kim; David J Moliterno; L David Hillis
Alleviation of cocaine-induced coronary vasoconstriction by nitroglycerin.
Journal of the American College of Cardiology 1991;18(2):581-6.